search for




 

Original Article
Educational Interventions to Enhance Adherence to Prophylactic Treatment in Korean Hemophilia Patients
Clin Pediatr Hematol Oncol 2018;25:38-42.
Published online April 30, 2018
© 2018 Korean Society of Pediatric Hematology-Oncology and Korean Society for Pediatric Neuro-Oncology

Ji Hyun Na, M.D.1, Ki Young Yoo, M.D.2, Ji Yoon Kim, M.D.3, Sang Kyu Park, M.D.4, Soon Ki Kim, M.D.5 , Eun Jin Choi, M.D.1

1Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu, 2Korean Hemophilia Foundation, Seoul, 3Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 4Department of Pediatrics, University of Ulsan College of Medicine, Ulsan, 5Department of Pediatrics,Inha University College of Medicine, Incheon, Korea
Correspondence to: Eun Jin Choi
Department of Pediatrics, Daegu Catholic University School of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Korea
Tel: +82-53-650-4248 Fax: +82-53-622-4240 E-mail: ejchoi2@cu.ac.kr
Received March 25, 2018; Revised April 5, 2018; Accepted April 9, 2018.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: A patient’s adherence to prophylactic treatment is one of the most significant factors to achieve desired outcomes, in regards to the quality of life and treatment cost-effectiveness. The aim of this study is to evaluate the effectiveness of educational interventions in enhancing adherence to prophylactic treatment in Korean hemophilia patients.
Methods: The Validated Hemophilia Regimen Treatment Adherence Scale-Prophylaxis (VERITAS-Pro) was used to measure adherence. The study design consisted of two groups. One group was not educated with the education card which presented the morning administration of clotting factor concentrates and self-infusion skill. The other group was educated with the card. The scores of each subscale in the two groups and scores focused on the ‘Timing’ subscale were compared.
Results: Participants were recruited from five hemophilia treatment centers in Korea with 95 eligible patients forming the uneducated group and 123 patients in the educated group. The mean total score was 40.4 and 39.9, respectively. The subscale mean scores of the uneducated group and educated group were 8.43 and 7.90 (Timing), 6.12 and 5.88 (Dosing), 6.43 and 6.33 (Planning), 5.99 and 6.35 (Remembering), 6.22 and 6.25 (Skipping), and 7.23 and 7.24 (Communicating), respectively.
Conclusion: Results showed that education programs on prophylactic treatment for he-mophilia patients need to be well-designed with precise and subject-appropriate contents. Although the mean total scores of VERITAS-Pro could not be improved, the appropriate timing of injection with the educational intervention was administered. Results suggest that this whole process can enhance Korean hemophilia patients’ adherence to prophylactic treatment.
Keywords: Adherence, Prophylaxis, Hemophilia, Education
References
  1. WFH Guidelines for the Management of Hemophilia. Montreal, Canada: World Federation of Hemophilia, 2012. (Accessed March 2, 2018, at http://www.wfh.org/en/resources/wfh-treatment-guidelines)
  2. Fischer K, Ljung R. Primary prophylaxis in haemophilia care: Guideline update 2016. Blood Cells Mol Dis 2017;67:81-5.
    Pubmed CrossRef
  3. Farrugia A, Cassar J, Kimber MC, et al. Treatment for life for severe haemophilia A-A cost-utility model for prophylaxis vs. on-demand treatment. Haemophilia 2013;19:e228-38.
    Pubmed CrossRef
  4. Giordano P, Lassandro G, Valente M, Molinari AC, Ieranò P, Coppola A. Current Management of the hemophilic child: a demanding interlocutor. Quality of Life and Adequate Cost-Efficacy Analysis. Pediatr Hematol Oncol 2014;31:687-702.
    Pubmed CrossRef
  5. Berntorp E. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens. Haemophilia 2009;15:1219-27.
    Pubmed CrossRef
  6. McLaughlin JM, Witkop ML, Lambing A, Anderson TL, Munn J, Tortella B. Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia. Haemophilia 2014;20:506-12.
    Pubmed CrossRef
  7. Choi EJ. Management of hemophilia in Korea: the past, present, and future. Blood Res 2014;49:144-5.
    Pubmed KoreaMed CrossRef
  8. Yoo KY, Choi YM, Hwang TJ, Choi EJ. The efficacy of prophylaxis for children with severe hemophilia in Korea-an experience of single institute. Clin Pediatr Hematol Oncol 2012;19:79-85.
  9. Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Hemophilia 2010;16:247-55.
    Pubmed CrossRef
  10. Coppola A, Di Capua M, De Simone C. Primary prophylaxis in children with haemophilia. Blood Transfus 2008;6(Suppl 2):s4-11.
    Pubmed KoreaMed
  11. Tagliaferri A, Franchini M, Coppola A, et al. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia 2008;14:945-51.
    Pubmed CrossRef
  12. Tagliaferri A, Feola G, Molinari AC, et al. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study. Thromb Haemost 2015;114:35-45.
    Pubmed CrossRef
  13. Coppola A, Tagliaferri A, Di Capua M, Franchini M. Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges. Semin Thromb Hemost 2012;38:79-94.
    Pubmed CrossRef
  14. Khawaji M, Astermark J, Berntorp E. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life. Eur J Haematol 2012;88:329-35.
    Pubmed CrossRef
  15. Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia 2013;19:355-61.
    Pubmed CrossRef
  16. Schrijvers LH, Schuurmans MJ, Fischer K. Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals. Haemophilia 2016;22:499-506.
    Pubmed CrossRef
  17. Schrijvers LH, Cnossen MH, Beijlevelt-Van der Zande M, Peters M, Schuurmans MJ, Fischer K. Defining adherence to prophylaxis in haemophilia. Haemophilia 2016;22:e311-4.
    Pubmed CrossRef
  18. Witkop ML, McLaughlin JM, Anderson TL, Munn JE, Lambing A, Tortella B. Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder. Haemophilia 2016;22:e245-50.
    Pubmed CrossRef
  19. Lock J, Raat H, Duncan N, et al. Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale. Haemophilia 2014;20:616-23.
    Pubmed CrossRef
  20. Miesbach W, Kalnins W. Adherence to prophylactic treatment in patients with haemophilia in Germany. Haemophilia 2016;22:e367-74.
    Pubmed CrossRef
  21. Penica S, Williams KE. The use of a psychological intervention to increase adherence during factor administration in a child with haemophilia. Haemophilia 2008;14:939-44.
    Pubmed CrossRef
  22. Thornburg CD, Duncan NA. Treatment adherence in hemophilia. Patient Prefer Adherence 2017;11:1677-86.
    Pubmed KoreaMed CrossRef
  23. De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia 2008;14:931-8.
    Pubmed CrossRef
  24. Hazendonk HCAM, van Moort I, Mathôt RAA, et al. Setting the stage for individualized therapy in hemophilia: what role can pharmacokinetics play? Blood Rev 2018 [Epub ahead of print].
    Pubmed CrossRef
  25. Barnes C. Importance of pharmacokinetics in the management of hemophilia. Pediatr Blood Cancer 2013;60:S27-9.
    Pubmed CrossRef
  26. Pasca S, Milan M, Sarolo L, Zanon E. PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A. Thromb Res 2017;157:58-63.
    Pubmed CrossRef


October 2018, 25 (2)
Full Text PDF
Citation
Send to a friend
Twitter
Facebook

Cited By Articles
  • CrossRef (0)

Author ORCID Information
  • Eun Jin Choi